Vaxart, Inc. Defined Contribution Plan, Cost
Vaxart, Inc. (VXRT) reported Defined Contribution Plan, Cost of $500.00 thousand for the 12-month period ending 2025-12-31, per its S-1 filed 2026-05-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-05-08
- Vaxart, Inc. defined contribution plan, cost for fiscal 2023 was $600.00K, a 14.29% decline from fiscal 2022.
- Vaxart, Inc. defined contribution plan, cost for fiscal 2022 was $700.00K, a 143.06% increase from fiscal 2021.
- Vaxart, Inc. defined contribution plan, cost for fiscal 2021 was $288.00K, a 200.00% increase from fiscal 2020.
- Vaxart, Inc. defined contribution plan, cost for fiscal 2020 was $96.00K, a 31.43% decline from fiscal 2019.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2025-12-31 | $500.00K S-1 · filed 2026-05-08 | |
| 2024-12-31 | $500.00K S-1 · filed 2026-05-08 | |
| 2023-12-31 | $600.00K 10-K · filed 2025-03-20 | |
| 2022-12-31 | $700.00K 10-K · filed 2024-03-14 | $658.00K 10-K · filed 2023-03-15 |
| 2021-12-31 | $288.00K 10-K · filed 2023-03-15 | |
| 2020-12-31 | $96.00K 10-K · filed 2022-02-24 | |
| 2019-12-31 | $140.00K 10-K · filed 2022-02-24 | |
| 2018-12-31 | $124.00K 10-K · filed 2021-02-25 | |
| 2017-06-30 | $200.00K 10-K · filed 2017-09-01 | |
| 2016-06-30 | $200.00K 10-K · filed 2017-09-01 | |
| 2015-06-30 | $400.00K 10-K · filed 2016-09-13 | |
| 2014-06-30 | $800.00K 10-K · filed 2016-09-13 | |
| 2013-06-30 | $1.10M 10-K · filed 2015-09-11 | |
| 2012-06-30 | $1.10M 10-K · filed 2014-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |